Kristian Humer - Jul 30, 2021 Form 4 Insider Report for Sensei Biotherapeutics, Inc. (SNSE)

Role
Director
Signature
/s/ Mark Ballantyne (Attorney-in-Fact)
Stock symbol
SNSE
Transactions as of
Jul 30, 2021
Transactions value $
$0
Form type
4
Date filed
8/2/2021, 04:20 PM
Previous filing
Jul 27, 2021
Next filing
Jan 3, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SNSE Stock Option (Right to Buy) Award $0 +16.7K $0.00 16.7K Jul 30, 2021 Common Stock 16.7K $7.89 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 One thirty-sixth (1/36th) of the shares underlying the option granted shall vest and become exercisable each month following July 30, 2021, over three years such that the options shall be 100% vested on July 30, 2024, subject to the grantee's Continuous Service (as defined in the Issuer's 2021 Equity Incentive Plan) through each such vesting date.